文献速递产科母胎医学

评估胎儿生长轨迹可识别围产期死亡高风险婴儿

Assessment of fetal growth trajectory identifies infants at high risk of perinatal mortality.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

这项队列研究纳入5319例单胎妊娠,分析妊娠后半期三种胎儿生长轨迹与围产期风险的关系。与参考组相比,生长轨迹下降且最终非小于胎龄儿(组2)和生长轨迹下降且最终小于胎龄儿(组3)的围产期死亡调整比值比显著升高,组3的aOR为7.71(95%CI 2.39-24.91)。仅组3的死产风险升高(aOR 5.69,95%CI 1.55-20.93),而持续小于胎龄儿但生长轨迹适当(组1)的死亡风险未显著升高。

要点

  • 生长轨迹下降且最终小于胎龄儿的胎儿围产期死亡风险最高(aOR 7.71)。
  • 持续小于胎龄儿但生长轨迹适当的胎儿围产期死亡风险未显著升高。
  • 生长轨迹下降的胎儿出生小于胎龄儿和早产风险均升高。

核心结论

  • 评估妊娠后半期的胎儿生长轨迹有助于识别围产期死亡和出生体重低于同孕龄第3百分位风险升高的婴儿。

研究设计与样本

  • 这项队列研究纳入单胎妊娠、于32+0至41+6周分娩、且在18+0周后至少进行两次间隔至少4周的超声检查的孕妇,最终研究队列包含5319例妊娠。

主要发现

  • 与参考组相比,组2的围产期死亡调整比值比显著升高(aOR 4.00,95%CI 1.36-11.22),组3亦显著升高(aOR 7.71,95%CI 2.39-24.91)。
  • 仅组3的死产风险升高(aOR 5.69,95%CI 1.55-20.93),组1的死亡风险未显著升高。
  • 三个组的出生小于胎龄儿风险均升高,组1最高(aOR 111.86,95%CI 62.58-199.95),组3为aOR 40.63(95%CI 29.01-56.92);两组中超过80%的婴儿出生时为小于胎龄儿,近半数出生体重低于第3百分位。
  • 三个组的早产风险均升高,组3最高(aOR 4.27,95%CI 3.23-5.64)。
  • 复合严重新生儿疾病风险在组1和组3升高,因胎儿状态不良行急诊剖宫产的风险仅在组3升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze perinatal risks associated with three distinct scenarios of fetal growth trajectory in the latter half of pregnancy compared with a reference group. METHODS: This cohort study included women with a singleton pregnancy that delivered between 32 + 0 and 41 + 6 weeks' gestation and had two or more ultrasound scans, at least 4 weeks apart, from 18 + 0 weeks. We evaluated three different scenarios of fetal growth against a reference group, which comprised appropriate-for-gestational-age fetuses with appropriate forward-growth trajectory. The comparator growth trajectories were categorized as: Group 1, small-for-gestational-age (SGA) fetuses (estimated fetal weight (EFW) or abdominal circumference (AC) persistently < 10th centile) with appropriate forward growth; Group 2, fetuses with decreased growth trajectory (decrease of ≥ 50 centiles) and EFW or AC ≥ 10th centile (i.e. non-SGA) at their final ultrasound scan; and Group 3, fetuses with decreased growth trajectory and EFW or AC < 10th centile (i.e. SGA) at their final scan. The primary outcome was overall perinatal mortality (stillbirth or neonatal death). Secondary outcomes included stillbirth, delivery of a SGA infant, preterm birth, emergency Cesarean section for non-reassuring fetal status and composite severe neonatal morbidity. Associations were analyzed using logistic regression. RESULTS: The final study cohort comprised 5319 pregnancies. Compared to the reference group, the adjusted odds of perinatal mortality were increased significantly in Group 2 (adjusted odds ratio (aOR), 4.00 (95% CI, 1.36-11.22)) and Group 3 (aOR, 7.71 (95% CI, 2.39-24.91)). Only Group 3 had increased odds of stillbirth (aOR, 5.69 (95% CI, 1.55-20.93)). In contrast, infants in Group 1 did not have significantly increased odds of demise. The odds of a SGA infant at birth were increased in all three groups compared with the reference group, but was highest in Group 1 (aOR, 111.86 (95% CI, 62.58-199.95)) and Group 3 (aOR, 40.63 (95% CI, 29.01-56.92)). In both groups, more than 80% of infants were born SGA and nearly half had a birth weight < 3rd centile. Likewise, the odds of preterm birth were increased in all three groups compared with the reference group, being highest in Group 3, with an aOR of 4.27 (95% CI, 3.23-5.64). Lastly, the odds of composite severe neonatal morbidity were increased in Groups 1 and 3, whereas the odds of emergency Cesarean section for non-reassuring fetal status were increased only in Group 3. CONCLUSION: Assessing the fetal growth trajectory in the latter half of pregnancy can help identify infants at increased risk of perinatal mortality and birth weight < 3rd centile for gestation. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Larsen ML, Krebs L, Hoei-Hansen CE, et al. Assessment of fetal growth trajectory identifies infants at high risk of perinatal mortality. Ultrasound Obstet Gynecol. 2024. PMID: 38339783. doi:10.1002/uog.27610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。